| 000 | 01714 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515181700.0 | ||
| 264 | 0 | _c20100111 | |
| 008 | 201001s 0 0 eng d | ||
| 022 | _a1432-0584 | ||
| 024 | 7 |
_a10.1007/s00277-009-0796-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHeintel, Daniel | |
| 245 | 0 | 0 |
_aNonpegylated liposomal doxorubicin is highly active in patients with B and T/NK cell lymphomas with cardiac comorbidity or higher age. _h[electronic resource] |
| 260 |
_bAnnals of hematology _cFeb 2010 |
||
| 300 |
_a163-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xtherapeutic use |
| 650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Diseases _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, T-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSkrabs, Cathrin | |
| 700 | 1 | _aHauswirth, Alexander | |
| 700 | 1 | _aEigenberger, Karin | |
| 700 | 1 | _aEinberger, Christine | |
| 700 | 1 | _aRaderer, Markus | |
| 700 | 1 | _aSperr, Wolfgang R | |
| 700 | 1 | _aKnöbl, Paul | |
| 700 | 1 | _aMüllauer, Leonhard | |
| 700 | 1 | _aUffmann, Martin | |
| 700 | 1 | _aDieckmann, Karin | |
| 700 | 1 | _aGaiger, Alexander | |
| 700 | 1 | _aJäger, Ulrich | |
| 773 | 0 |
_tAnnals of hematology _gvol. 89 _gno. 2 _gp. 163-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00277-009-0796-5 _zAvailable from publisher's website |
| 999 |
_c19044639 _d19044639 |
||